SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-004881
Filing Date
2011-05-10
Accepted
2011-05-10 17:10:31
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2204014z10-q.htm 10-Q 1073969
2 EX-2.4 a2204014zex-2_4.htm EX-2.4 24736
3 EX-31.1 a2204014zex-31_1.htm EX-31.1 8717
4 EX-31.2 a2204014zex-31_2.htm EX-31.2 9630
5 EX-32.1 a2204014zex-32_1.htm EX-32.1 5696
6 EX-32.2 a2204014zex-32_2.htm EX-32.2 6571
  Complete submission text file 0001047469-11-004881.txt   4876977

Data Files

Seq Description Document Type Size
7 EX-101.INS vrx-20110331.xml EX-101.INS 623115
8 EX-101.SCH vrx-20110331.xsd EX-101.SCH 45663
9 EX-101.CAL vrx-20110331_cal.xml EX-101.CAL 78318
10 EX-101.LAB vrx-20110331_lab.xml EX-101.LAB 516547
11 EX-101.PRE vrx-20110331_pre.xml EX-101.PRE 215005
12 EX-101.DEF vrx-20110331_def.xml EX-101.DEF 150329
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 11829217
SIC: 2834 Pharmaceutical Preparations